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ABSTRACT The reversible aggregation of human red blood cells (RBC) by proteins or polymers continues to be of biologic
and biophysical interest, yet the mechanistic details governing the process are still being explored. Although a depletion model
with osmotic attractive forces due to polymer depletion near the RBC surface has been proposed for aggregation by the neutral
polyglucose dextran, its applicability at high molecular mass has not been established. In this study, RBC aggregation was
measured over a wide range of dextran molecular mass (70 kDa to 28 MDa) at concentrations #2 g/dL. Our results indicate that
aggregation does not monotonically increase with polymer size; instead, it demonstrates an optimum dextran molecular mass
around 200-500 kDa. We used a model for depletion-mediated RBC aggregation to calculate the expected depletion energies.
This model was found to be consistent with the experimental results and thus provides new insight into polymer-RBC interactions.
INTRODUCTION
The reversible aggregation of human red blood cells (RBC)
continues to be of interest in the ﬁeld of hemorheology be-
cause RBC aggregation is a major determinant of the in vitro
rheological properties of blood. Enhanced aggregation in-
creases low shear blood viscosity and the degree of non-
Newtonian behavior (1,2). In addition, the in vivo ﬂow
dynamics and ﬂow resistance of blood are inﬂuenced by
RBC aggregation (3), and marked increases of RBC aggre-
gation have been observed in several diseases associated with
vascular disorders (e.g., diabetes mellitus, hypertension).
Measures of RBC aggregation, such as the erythrocyte sed-
imentation rate (ESR), are commonly used as diagnostic tests
and as one index to the efﬁcacy of therapy. For example, ESR
is measured during drug therapy for rheumatoid arthritis, and
has been shown to be normalized by improved glycemic
control in diabetes (4). There is now general agreement
regarding the correlations between elevated levels of ﬁ-
brinogen or other large plasma proteins and enhanced RBC
aggregation, and the effects of molecular mass and concen-
tration for neutral polymers have been reported (5). However,
the speciﬁc mechanisms involved in RBC aggregation have
not been fully elucidated, and thus it is not yet possible to
fully understand the relations between pathology and altered
RBC aggregation.
RBC form multicell linear or branched aggregates in vitro
when they are suspended in either plasma or solutions con-
taining large polymers (e.g., dextran $40 kDa); RBC ag-
gregates also form in vivo in regions of low ﬂow or stasis and,
hence, in regions of low shear. These linear forms are often
termed rouleaux because they resemble a stack of coins.
It is important to note that RBC aggregation is a reversible
process, with aggregates dispersed by mechanical or ﬂuid
ﬂow forces and then reforming when the forces are removed.
Conversely, RBC agglutination and blood coagulation are
irreversible processes due to either protein polymerization or
strong antigen-antibody attractive forces. RBC aggregation is
primarily determined by the type and concentration of poly-
mers in solution or the plasma level of large proteins and by
RBC aggregability (i.e., the intrinsic cell characteristics af-
fecting RBC aggregation) (6). In blood, the protein ﬁbrino-
gen is a primary determinant of blood viscosity due to its
strong tendency to increase both plasma viscosity and RBC
aggregation (7). In the past, most reports have primarily ex-
amined the ability of plasma proteins to promote aggregation;
for example, higher ﬁbrinogen levels have been linked to
elevated blood viscosities in hypertensive patients (8).
To our knowledge, there are two coexisting models for
RBC aggregation: bridging and depletion. In the bridging
model, RBC aggregation is proposed to occur when the
bridging forces due to the adsorption of macromolecules onto
adjacent cell surfaces exceed disaggregating forces due to
electrostatic repulsion, membrane strain, and mechanical
shearing (9). This model seems to be similar to other cell in-
teractions such as agglutination; the only difference is that the
suggested adsorption energy of the macromolecules is much
smaller to be consistent with the relative weakness of the
aggregation forces. In contrast, the depletion model proposes
quite the opposite. In thismodel, RBC aggregation occurs as a
result of a lower localized protein or polymer concentration
near the cell surface compared to the suspendingmedium (i.e.,
relative depletion near the cell surface). This exclusion of
macromolecules near the cell surface leads to an osmotic
gradient, depletion interaction, and attractive forces (10). As
with the bridging model, disaggregation forces are electro-
static repulsion, membrane strain, and mechanical shearing.
Several previous reports have examined the experimental
and theoretical aspects of depletion aggregation, often termed
depletion ﬂocculation, as applied to the general ﬁeld of col-
doi: 10.1529/biophysj.108.130328
Submitted February 5, 2008, and accepted for publication June 9, 2008.
Address reprint requests to Dr. Bjo¨rn Neu, Division of Bioengineering,
Nanyang Technological University, 70 Nanyang Dr., Singapore 639798.
Tel.: 65-6790-6951; Fax: 65-6791-1761.
Editor: Denis Wirtz.
 2008 by the Biophysical Society
0006-3495/08/09/3059/07 $2.00
Biophysical Journal Volume 95 September 2008 3059–3065 3059
loid chemistry (11–13). However, polymer depletion as a
mechanism for RBC aggregation has received much less
attention, with only a few reports in the literature relevant to
this approach (10,14–17). Although the depletion model is
consistent with reports of polymer-induced aggregation
(18,19), an apparent ﬂaw of the model arises from the de-
scription of RBC-RBC interactions for cells suspended in
solutions of very high molecular mass polymers (e.g.,
dextran . 500 kDa). Using dextran fractions ranging in mo-
lecular mass from 40 to 500 kDa and conductance, optical,
ultrasound, and viscometric methods, several investigators
have indicated that, with increasing molecular weight, dex-
tran fractions become increasingly more effective in causing
rouleaux formation (20–22). Conversely, a depletion-
mediated aggregation mechanism is more likely to have a
nonmonotonic dependence on molecular mass (i.e., declining
aggregation above a certain molecular mass), with the rela-
tion dependent on the polymer’s physicochemical properties
and on the nature of the RBC soft surface layer (i.e., its
glycocalyx). This study was thus designed to examine the
relations between RBC aggregation and afﬁnity versus dex-
tran molecular mass.
MATERIAL AND METHODS
Sample preparation
Blood was drawn from the antecubital vein of healthy adult volunteers into
EDTA (1.5 mg/mL), and all measurements were performed within 6 h after
venesection. The following dextran fractions were dissolved in phosphate-
buffered saline (PBS, 0.01 M phosphate, pH 7.4, 2956 5 mOsmL/kg) at the
desired ﬁnal concentrations (in molecular mass): 40 kDa, 70 kDa, 250 kDa,
500 kDa, 2 MDa, and 28 MDa. The dextran fractions were obtained from
Sigma Chemical, St. Louis, MO; TDB Consultancy, Uppsala, Sweden; and
Amersham Pharmacia Biotech, Uppsala, Sweden. The 28 MDa dextran was
prepared by dialyzing a 10-20 MDa fraction from Amersham Pharmacia
Biotech to remove some lower molecular mass species, then analyzed by
viscometry and quasielastic light scattering (Wyatt Technology, SantaBarbara,
CA); only viscometry was used for the other fractions. RBC were separated
fromwhole blood via 2,0003 g centrifugation for 10 min, and the plasma and
buffy coat were removed. The RBC were washed twice in PBS, then re-
suspended in the desired polymer solution at a hematocrit of 40 6 0.3% for
aggregation studies.
Aggregation measurements
The extent of RBC aggregation at stasis was measured using a transparent
cone-plate shearing instrument (Aggregometer Model MA-2; Myrenne,
Roentgen, Germany) that uses the light transmission method of Klose et al.
(23). This technique is based on the increase of light transmission through an
RBC suspension that occurs when individual cells aggregate into rouleaux or
rouleaux-rouleaux complexes; gaps in the suspending medium between the
aggregates allowmore light to pass through theRBCsuspension. In our study,
the Myrenne Aggregometer was modiﬁed, as described previously (24): 1),
light transmission data were digitized and recorded using an analog/digital
converter interfaced to a laboratory computer; and 2), the computer controlled
the shear rate in the cone-plate portion of the instrument. In operation, the
blood sample is ﬁrst brieﬂy sheared at 600 s1 to disperse all preexisting
aggregates; then the shear rate abruptly is decreased to zero, after which light
transmission is integrated for 10 seconds. The dimensionless numeric value
resulting from this integration is termed M. The sample is then again brieﬂy
sheared at 600 s1, after which the shear rate is abruptly reduced to 3 s1, and
the light transmission is again integrated for 10 s. The dimensionless numeric
value resulting from this integration is termed M1. Note that M reﬂects the
extent of RBC aggregation at stasis and that M1 reﬂects the extent of aggre-
gation under conditions at which low ﬂuid shear promotes cell-cell contact;
both M and M1 increase with increasing RBC aggregation (24).
Miscellaneous techniques
RBC suspension hematocrits were determined by an automated hematology
analyzer (Micros; ABX Diagnostics, Irvine, CA), solution osmolalities by a
freezing-point osmometer (model 5004; Precision Systems, Natick, PA), and
pH by an Orion system (model 410A; Orion Research, Boston, MA). The
viscosity of all suspending media was measured at 25C by capillary vis-
cometry (Plasma Viscometer II; Coulter Electronics, Luton, UK. In addition,
the viscometer was used to determine the intrinsic viscosity [h] of the various
polymers by extrapolation of their speciﬁc viscosity/concentration ratios to
zero concentration (25); intrinsic viscosity values were used to obtain ag-
gregation-molecular mass relations at several ﬁxed levels of suspending
media viscosity. The presence of RBC aggregation was observed micro-
scopically using low hematocrit wet mounts of cells suspended in the ap-
propriate medium.
Theory
We have recently proposed a theoretical model to evaluate depletion-medi-
ated RBC interactions in polymer solutions (18). In this study, we outline a
simpliﬁed approach for evaluating depletion energies in polymer solutions. If
a surface is in contact with a polymer solution and the loss of conﬁguration
entropy of the polymer is not balanced by adsorption energy, a depletion
layer develops near the surface. Within this layer. the polymer concentration
is lower than in the bulk phase. Thus, as two RBC approach, the difference of
solvent chemical potential (i.e., the osmotic pressure difference) between the
intercellular polymer-poor depletion zone and the bulk phase results in sol-
vent displacement into the bulk phase and hence depletion interaction. Due to
this interaction, an attractive force develops that tends to minimize the poly-
mer-reduced space between the cells and thus promotes aggregation (26).
Examination of the energetics of depletion layers requires distinguishing
between so-called hard and soft or hairy surfaces. Hard surfaces are con-
sidered to be smooth and do not allow polymer penetration into the surface,
whereas soft surfaces, such as the RBC glycocalyx, are characterized by a
layer of attached macromolecules that can be penetrated, in part or entirely,
by the free polymer in solution (13,26). For two adjacent cells with soft
surfaces at a separation distance d, a glycocalyx thickness d, a depletion layer
thickness D, and a penetration p of the polymers into the glycocalyx, the
depletion interaction energy wD can be approximated by the following (18):
wD ¼ 2P D d
2
1 d p
 
(1)
for (d/2  d1 p)# D and is zero for (d/2  d1 p). D. For small polymer
concentrations the osmotic pressure term P is given by the following:
P ¼ RT
M
c
b
; (2)
where R, T, and M are the gas constant, absolute temperature, and the
molecular mass of the polymer, respectively, and cb represents the bulk
polymer concentration. The depletion layer thickness D depends on the
polymer concentrations. However, at small concentrations, it can be approx-
imated by 1.43Rg, withRg being the polymer’s radius of gyration. In turn,Rg
can be calculated by the relation Rg ¼ AecM0:5w with Aec for dextran equal to
0.88 nmmol0.5kg0.5.
To compute the dependence of the depletion energy on molecular mass,
we can set the distance d in Eq. 1 equal to twice the glycocalyx thickness d.
This leads to the following expression for the depletion energy:
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wD ¼ 2RT
M
c
b

1:4  Aec
ﬃﬃﬃﬃ
M
p
 p

: (3)
Because the depletion energy is zero if the term in brackets is smaller or equal
to zero, 1:4  Aec
ﬃﬃﬃﬃ
M
p
together with the penetration p deﬁnes a threshold
molecular mass for depletion interaction.
It should be noted that the penetration depth p of the free polymer into the
attached layer should depend on the polymer type, concentration, and mo-
lecular size. It also would be expected to be larger for small molecules and to
increase with increasing polymer concentration due to increasing osmotic
pressure. One possibility is to calculate p by assuming that penetration pro-
ceeds until the local osmotic pressure developed in the attached layer is bal-
anced by the osmotic pressure of the bulk solution (13). It is also possible to
consider that the attached polymers collapse under the osmotic pressure of the
bulk polymer (27). However, it is difﬁcult to accurately apply such amodel to
RBC in polymer or protein solution because too little is known about the
physicochemical properties of the glycocalyx and, in particular, about the
interaction between the glycocalyx and different polymers or proteins.
RESULTS
RBC aggregation
Prior studies of dextran-induced RBC aggregation have fo-
cused on molecular mass #2 MDa (28), and thus a series of
measurements were conducted using ﬁve molecular mass
dextran fractions (i.e., 70, 250, and 500 kDa; 2 and 28MDa) at
concentrations of$2 g/dL. The viscosities of the suspending
phase solutions are shown in Fig. 1. RBC aggregation results
for 3–5 different donors are presented in Figs. 2 through Fig.
6, with panel A in each Fig. showing theM values and panel B
showing theM1 values. The relatively small variations of the
aggregation indices at the same concentration are expected,
because the data points were obtained using different donors
and, hence, are affected by donor/donor differences of cellular
factors affecting aggregation in a deﬁned polymer solution
(i.e., differences of RBC aggregability) (1). Further, the ex-
FIGURE 1 Viscosity concentration results for dextran molecular mass
fractions used in this study. Data were obtained at 25C using an automated
tube viscometer.
FIGURE 2 Experimentally determined polymer concentration-RBC ag-
gregation data. (A)M value and (B)M1 value for cells suspended in solutions
of dextran having a molecular mass of 70 kDa. Solid lines represent the best
ﬁts via a third-order polynomial (y ¼ A 1 B1x 1 B2x2 1 B3x3).
FIGURE 3 Experimentally determined polymer concentration-RBC ag-
gregation data. (A)M value and (B)M1 value for cells suspended in solutions
of dextran having a molecular mass of 250 kDa. Solid lines represent the best
ﬁts via a third-order polynomial (y ¼ A 1 B1x 1 B2x2 1 B3x3).
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perimental data indicate that the aggregation-concentration
relations for the 70 kDa through 2 MDa fractions have simi-
lar shapes, with a minimum concentration needed to initiate
aggregation (M value . 0) and a steady increase of aggre-
gation with concentration. The 28 MDa fraction (Fig. 6) also
exhibits a minimum concentration to initiate aggregation, but
reaches a maximal M value of ;5 around 0.5 g/dL and then
declines with increasing concentration. The range of the M
values for RBC in 28 MDa dextran indicate only very low
levels of aggregation (Fig. 6 A), and theM1 values (Fig. 6 B)
show relatively weak dependence on the polymer concen-
tration with an average value of ;12.8, thus indicating no
stable rouleaux formation at a shear rate of 3 s1.
TheM or M1 versus concentration data were then ﬁtted to
third-order polynomial functions of the form y ¼ A1 B1x1
B2x
2 1 B3x
3, with regression results and ﬁtting parameters
also presented in each panel of Figs. 2–6. Inspection of these
ﬁgures indicates that the data points are well-ﬁtted by the
polynomial functions, with mostR2 values$ 0.8 (p, .0001).
The results in Figs. 2–6were then used to calculate the mo-
lecular mass-dependence of aggregation at constant polymer
concentration and at constant suspending phase viscosity
(see Materials and Methods). Fig. 7 shows calculated aggre-
gation at constant concentrations ranging from 0.25 g/dL to
0.9 g/dL. Regardless of concentration, the curves are clearly
bell-shaped with maximal aggregation at a molecular mass
;500 kDa. Although, in general, the molecular mass for
maximal aggregation does not show a signiﬁcant dependence
on polymer concentration, the relationship becomes broader
and less deﬁned at lower concentrations and suggests a shift
toward higher molecular mass. Fig. 8 shows calculated ag-
gregation at constant suspending phase viscosities ranging
from 1.1mPas to 1.4mPas. Relations similar to those shown
in Fig. 7 were observed. The molecular mass for maximal
aggregation is essentially independent of suspending media
viscosity, with broadening at lower viscosity and hence lower
dextran concentration.
Theoretical considerations
Fig. 9 presents calculated depletion energies at a bulk polymer
concentration cb of 0.5 g/dL and a glycocalyx thickness of
5 nm for a cell-cell separation of twice the glycocalyx thick-
ness (Eq. 3). For a hard surface (p ¼ 0), wD depends linearly
on cb2=M
0:5: Thus, at constant concentration, the depletion
energywD decreases with increasing molecular mass (Fig. 9).
This decrease of wD and hence of aggregation tendency is in
opposition to the usually reported steady increase of RBC
aggregation in polymer solutions of increasing molecular
mass (20–22). For a completely penetrable soft glycocalyx
FIGURE 4 Experimentally determined polymer concentration-RBC ag-
gregation data. (A)M value and (B)M1 value for cells suspended in solutions
of dextran having a molecular mass of 500 kDa. Solid lines represent the
best ﬁts via a third-order polynomial (y ¼ A 1 B1x 1 B2x2 1 B3x3).
FIGURE 5 Experimentally determined polymer concentration-RBC ag-
gregation data. (A)M value and (B)M1 value for cells suspended in solutions
of dextran having a molecular mass of 2 MDa. Solid lines represent the best
ﬁts via a third-order polynomial (y ¼ A 1 B1x 1 B2x2 1 B3x3).
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(p¼ 5 nm), depletion interaction only occurs above aminimal
molecular mass (.16.5 kDa); the depletion energy then in-
creases until it reaches a maximum at a molecular mass;100
kDa, after which it declines asymptotically toward zero.
For largermolecular mass, especially.1MDa, the difference
between hard and soft surface diminishes. Thus the above-
mentioned theoretical result for a soft surface (p ¼ 5 nm) is
qualitatively similar to the experimental data presented in
Figs. 7 and 8: depletion interaction only occurs above a min-
imal molecular mass; the depletion energy then increases,
reaches a maximum afﬁnity, and then declines. This agree-
ment between theoretically predicted behavior and experi-
mental results lends credence to a mechanism governed by
depletion interaction between soft surfaces.
DISCUSSION
Using a wide range of dextran molecular mass fractions (i.e.,
70–28,000 kDa), our experimental results clearly support a
depletion-mediated model for the aggregation of human RBC
by the neutral, water-soluble polymer dextran. Although di-
rect numeric comparisons between the experimentally mea-
sured extent of aggregation and the theoretically derived
depletion energies is not possible, the relations between these
two variables are consistent with our ﬁndings that increasing
or decreasing theoretical depletion interaction leads to in-
creasing or decreasing experimental RBC aggregation (Figs.
7 and 8). Further, in contrast to previous reports indicating
increased aggregation with increased molecular mass (20–
22), our experimental results indicate optimal or maximum
aggregation at ;500 kDa (Fig. 6). This molecular mass for
maximal experimental aggregation is the same order of mag-
nitude as the maximal depletion interaction predicted theo-
retically (Fig. 9). Our data thus suggest that the bridging
model for polymer-induced RBC aggregation can be re-
jected, at least for dextran-induced aggregate formation. The
extent to which these ﬁndings can be extended to other
neutral polymers, to charged polymers, and to speciﬁc pro-
teins requires additional study.
Although the current depletion model appears robust, it
does not consider polymer adsorption onto the RBC surface
and so the possible effects of steric interactions or altered
depletion layer thickness due to adsorbed polymer. Experi-
mental results for dextran adsorption onto human RBC have
been presented (29,30). However, it has also been shown that
RBC adsorption data for dextran and proteins are subject to
FIGURE 6 Experimentally determined polymer concentration-RBC ag-
gregation data. (A)M value and (B)M1 value for cells suspended in solutions
of dextran having a molecular mass of 28 MDa. Solid lines represent the
best ﬁts via a third-order polynomial (y ¼ A 1 B1x 1 B2x2 1 B3x3).
FIGURE 7 Calculated dependence of RBC aggregation on molecular
mass at different suspending phase polymer concentrations. (A)M value and
(B) M1 value. Data points were computed based on the experimental results
shown in Figs. 2–6.
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potential artifacts and are quantitatively difﬁcult to interpret
(31), thus making their application to the current model ten-
uous. In addition, our current model has drawbacks that are
quite likely due to its simplicity. For example, in future
studies, it will be necessary to focus on more realistic treat-
ments of the RBC glycocalyx (e.g., thickness and structure)
and how it interacts with polymers or proteins. Such an ap-
proach should help in obtaining a quantitative understanding
of the molecular mass dependence of aggregation. Lastly, it
should be emphasized that only depletion interaction was
considered in our calculations. Repulsive forces such as an
electrostatic Coulomb force or forces due to the elastic defor-
mation of RBC during aggregation have not been considered.
Clearly, such additional forces will tend to inhibit aggregation
until a critical threshold energy has been achieved. Conse-
quently, the threshold for depletion interaction to occur is
expected to be below that required for observable and mea-
surable aggregation (18).
In overview, our ﬁndings provide important new insights
into polymer-RBC interactions and thus the stabilization and
destabilization of suspensions of biologic particles or cells. In
particular, the model should be useful in the development of
biocompatible infusion ﬂuids such as plasma expanders. Note
the design of such ﬂuids requires a balance between 1), re-
tention in the circulatory system for a desired time period (i.e.,
not rapidly excreted by the kidneys) and so a large polymer;
and 2), either reduced or unaltered cell-cell adhesion such as
RBC aggregation and so a small polymer (32,33). Further,
it would be of interest to apply this model to currently un-
resolved aspects of human RBC aggregation, such as the re-
duced aggregation of neonatal RBC in both plasma and in
polymer solutions (34). Application of this model may also be
of potential value in human disease, in that disturbed in vivo
blood ﬂow consequent to elevated RBC aggregation has been
observed in clinical states such as diabetes mellitus, myo-
cardial infarction, and renal disease (33). A clearer under-
standing of polymer-glycocalyx interactions should allow
rationale development of therapeutic agents for improvement
of microcirculatory ﬂow.
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